Compared with the SHAM group, ANP and β-MHC mRNA levels were significantly increased and α-MHC mRNA levels were significantly decreased in the CKD group; the increasing trend of BNP mRNA levels was also observed in the CKD group, despite no statistically difference. The gene discussed is NPPA; the disease is chronic kidney disease.